Bristol-Myers Squibb Announces Dividend
NEW YORK--(BUSINESS WIRE)--Jun 14, 2018--The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty cents ($0.40) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on August 1, 2018, to stockholders of record at the close of business on July 6, 2018.
The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable September 4, 2018 to stockholders of record at the close of business on August 7, 2018.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180614006037/en/
CONTACT: Bristol-Myers Squibb Company
Ken Dominski, 609-252-5251
Lisa McCormick Lavery, 609-252-7602
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2018.
PUB: 06/14/2018 04:30 PM/DISC: 06/14/2018 04:31 PM